Disease Management Programmes (DMPs) are proposed to enhance the quality of care, to improve health outcomes and to reduce costs. Yet, the evidence regarding the effectiveness of such structured approaches remains uncertain. Randomized controlled trials (RCTs) represent the gold standard of evaluation for complex interventions. However, most of the evidence derives from non-randomized or even uncontrolled trials. We therefore tried to assess the impact of a randomized control group on the interpretation of DMP effectiveness.
Useful keywords (using NLM MeSH Indexing)
Diabetes Mellitus, Type 2/economics
Diabetes Mellitus, Type 2/therapy*
Hemoglobin A, Glycosylated/metabolism*